We added the following clinical trials to Metastatic Trial Search for December 2024. To see all clinical trials, please visit Metastatic Trial Search.

ER or PR Positive Trials

• RYZ101 Radioactive Drug with Immunotherapy for Advanced ER+, HER2- Breast Cancer Expressing SSTRs
  
• Alisertib Targeted Therapy with Hormone Therapy for Advanced HR+, HER2- Breast Cancer

HER2 Negative Trials

• Axatilimab Immunotherapy with Targeted Therapy for Metastatic HER2 Negative Breast Cancer with BRCA1/2 or PALB2 Mutations
• ATX-559 Targeted Therapy for Advanced HER2-/BRCA+ or dMMR/MSI-H Breast Cancer

HER2 Positive Trials

• TransCon IL-2 Immunotherapy with Trastuzumab or Trastuzumab Emtansine (T-DM1) for Metastatic 3rd Line or Later HER2+ Breast Cancer
• BBO-10203 Targeted Therapy with Trastuzumab for Advanced HER2+ or HR+, HER2- Breast Cancer

Triple Negative Trials

• STX-001 mRNA Injection with Pembrolizumab for Advanced Triple Negative Breast Cancer
• JANX008 Targeted Therapy for Advanced Triple Negative Breast Cancer

Other Stage IV Trials

• Usual Radiation Therapy Compared to Longer Radiation Therapy for People with Brain Metastases
• ALTA2618 Targeted Therapy for Advanced Breast Cancer with AKT1 E17K Mutations
• Arginine and Whole Brain Radiation Therapy for People with Brain Metastases

Last Modified on December 2, 2024